XML 60 R49.htm IDEA: XBRL DOCUMENT v3.25.3
ALLIANCES - Financial Information Pertaining to Alliances (SystImmune) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
SystImmune      
Alliance Statement [Line Items]      
Consideration for contingent development and regulatory approval   $ 7,600  
Acquired IPRD $ 250    
Upfront payments paid to collaborative partner     $ 800
BioNTech      
Alliance Statement [Line Items]      
Upfront payments to be paid to collaborative partner   1,500  
Consideration for contingent development and regulatory approval   $ 7,600